We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

BioInvent and ThromboGenics Complete Phase I Patient Trial of Anti-PlGF Cancer Therapeutic

News   Nov 17, 2009

 
BioInvent and ThromboGenics Complete Phase I Patient Trial of Anti-PlGF Cancer Therapeutic
 
 
 

RELATED ARTICLES

Study Suggests a Lack of Racial Diversity in Cancer Drug Trials

News

A new study has found that fewer than 8% of cancer drug trials reported participation from the four major races in the United States – white, Asian, black and Hispanic – between 2008 and 2018.

READ MORE

Ebola Patients Have a 90% Survival Rate After Injection With New Drugs

News

Two Ebola drugs have proven so effective in a clinical trial that researchers will make the treatments available to anyone infected with the virus in the Democratic Republic of the Congo, where Ebola has killed nearly 1,900 people over the past year.

READ MORE

Sticky Proteins Help Plants Know When – and Where – to Grow

News

Depending on the temperature, a plant may synthesize the hormone auxin. Depending on the pathogens present, a plant may synthesize auxin. Depending on the available nutrients, water, stressors or development cues: auxin. An interdisciplinary team has recently uncovered a mechanism by which a plant can be affected in a myriad of ways based on the presence of the same hormone.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE